Alterity Therapeutics (ATHE) Accumulated Expenses (2023 - 2025)

Alterity Therapeutics has reported Accumulated Expenses for 3 years, with the latest figure at $1.1 million in Q2 2025.

• For the quarter ending Q2 2025, Accumulated Expenses rose 885.89% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2025 stood at $1.1 million (up 885.89% YoY), and the FY2025 full-year result was $1.1 million, up 885.89% from the prior year.
• Accumulated Expenses for Q2 2025 stood at $1.1 million, up from $109439.6 in the prior quarter.
• The five-year high for Accumulated Expenses was $1.1 million in Q2 2025, with the low at $109439.6 in Q2 2024.
• Average Accumulated Expenses over 3 years is $721023.6, with a median of $974676.7 recorded in 2023.
• Year-over-year, Accumulated Expenses sank 88.77% in 2024 and soared 885.89% in 2025.
• Tracing ATHE's Accumulated Expenses over 3 years: stood at $974676.7 in 2023, then slumped by 88.77% to $109439.6 in 2024, then soared by 885.89% to $1.1 million in 2025.
• The last three Accumulated Expenses figures came in at $1.1 million (Q2 2025), $109439.6 (Q2 2024), and $974676.7 (Q2 2023), per Business Quant data.

Peer Comparison